Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 3/2018

Open Access 01-09-2018 | Consensus

RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India

Authors: P. V. Rao, B. M. Makkar, Ajay Kumar, A. K. Das, A. K. Singh, Ambrish Mithal, Anil Bhansali, Anoop Misra, Anuj Maheshwari, Arvind Gupta, Ashu Rustogi, Banshi Saboo, C. H. Vasanth Kumar, C. R. Anand Moses, Hemant Thacker, Jayant Panda, Jayaprakashsai Jana, Jothydev Kesavdev, K. R. Narasimha Setty, Manoj Chawla, Neeta Deshpande, Nikhil Tandon, Rajeev Chawla, Rajeev Kovil, Rakesh Sahay, S. V. Madhu, Samar Banerjee, Sanjay Agarwal, Sanjay Kalra, Sarita Bajaj, Shashank R Joshi, S. R. Aravind, Subhankar Chowdhury, Sujoy Ghosh, Sunil Gupta, Viswanathan Mohan, Vijay Panikar, Vijay Viswanathan

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2018

Login to get access

Abstract

Maintaining a good glycemic control is crucial in the management of diabetes mellitus (DM) as it is associated with the reduction in both macro and microvascular complications of the disease. Self-monitoring of blood glucose (SMBG), which provides the day-to-day blood glucose levels, is a simple and practical tool for maintaining a good glycemic control. Although SMBG is widely practiced in other countries, its use in India is very limited. Even when used, it is not carried out is a structured manner. There seems to be a lack of education about the purpose of SMBG and the correct process and schedule to be followed. This highlights the unmet need for country-specific SMBG recommendations. In order to fulfil this need, a panel of expert endocrinologists/ diabetologists came together under the aegis of Research Society for the Study of Diabetes in India (RSSDI). They reviewed the current literature, combined the evidences with their clinical knowledge and expertise, and developed consensus recommendations for SMBG practice in India. This document provides a comprehensive review of the current literature on SMBG and presents the recommendations made by the expert panel.
Literature
1.
Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes—a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000;50(Suppl 2):S77–84.PubMedCrossRef
2.
Yesudian CA, Grepstad M, Visintin E, Ferrario A. The economic burden of diabetes in India: a review of the literature. Glob Health. 2014;10:80.CrossRef
3.
Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, Del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016;7(17):354–95.PubMedPubMedCentralCrossRef
4.
Scambler S, Newton P, Asimakopoulou K. The context of empowerment and self-care within the field of diabetes. Health (London). 2014;18(6):545–60.CrossRef
5.
6.
Nakagami T, Qiao Q, Carstensen B, Nhr-Hansen C, Hu G, Tuomilehto J, et al. Age, body mass index and type 2 diabetes—associations modified by ethnicity. Diabetologia. 2003;46(8):1063–70.PubMedCrossRef
7.
Mohan V. Why are Indians more prone to diabetes? J Assoc Physicians India. 2004;52:468–74.PubMed
8.
9.
Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9(6):767–80.PubMedCrossRef
10.
Acharya LD, Rau NR, Udupa N, Rajan MS, Vijayanarayana K. Assessment of cost of illness for diabetic patients in south Indian tertiary care hospital. J Pharm Bioallied Sci. 2016;8(4):314–20.PubMedPubMedCentralCrossRef
11.
Bhansali A. Cost of diabetes care: prevent diabetes or face catastrophe. J Assoc Physicians India. 2013;61(2):95.PubMed
12.
Kumpatla S, Kothandan H, Tharkar S, Viswanathan V. The costs of treating long-term diabetic complications in a developing country: a study from India. J Assoc Physicians India. 2013;61(2):102–9.PubMed
13.
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.PubMedPubMedCentralCrossRef
14.
Vasudevan AR, Burns A, Fonseca VA. The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus. Treat Endocrinol. 2006;5(5):273–86.PubMedCrossRef
15.
Cavalot F. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Diabetes Obes Metab. 2013;15(Suppl 2):3–8.PubMedCrossRef
16.
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–17.PubMedCrossRef
17.
Leal J, Hayes AJ, Gray AM, Holman RR, Clarke PM. Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data. Diabetes Care. 2013;36(6):1541–6.PubMedPubMedCentralCrossRef
18.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.CrossRef
19.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.CrossRef
20.
Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686–93.CrossRef
21.
22.
Vashist SK. Continuous glucose monitoring systems: a review. Diagnostics (Basel). 2013;3(4):385–412.CrossRef
23.
24.
Kesavadev J, Sadikot S, Wangnoo S, Kannampilly J, Saboo B, Aravind SR, et al. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM. Diabetes Metab Syndr. 2014;8(3):187–95.PubMedCrossRef
25.
Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288–98.PubMedCrossRef
26.
Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE, et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61(1):48–57.PubMedCrossRef
27.
Liang S, Yin H, Wei C, Xie L, He H, Liu X. Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. J Diabetes Metab Disord. 2017;16:45.PubMedPubMedCentralCrossRef
28.
Lin CC, Yang CP, Li CI, Liu CS, Chen CC, Lin WY, et al. Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan diabetes study. BMC Med. 2014;12:165.PubMedPubMedCentralCrossRef
29.
Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B, et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33(10):2169–74.PubMedPubMedCentralCrossRef
30.
Wei F, Sun X, Zhao Y, Zhang H, Diao Y, Liu Z. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus. BMC Nephrol. 2016;17(1):67.PubMedPubMedCentralCrossRef
31.
Benjamin EM. Self-monitoring of blood glucose: the basics. Clin Diabetes. 2002;20:45–7.CrossRef
32.
Speight J, Browne JL, Furler JS. Testing times! Choosing wisely when it comes to monitoring type 2 diabetes. Med J Aust. 2015;203(9):354–6.PubMedCrossRef
33.
34.
Clar C, Barnard K, Cummins E, Royle P, Waugh N, Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1–140.CrossRefPubMed
35.
Parkin CG, Buskirk A, Hinnen DA, Axel-Schweitzer M. Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes. Diabetes Res Clin Pract. 2012;97(1):6–15.PubMedCrossRef
36.
Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care. 2011;34(2):262–7.PubMedPubMedCentralCrossRef
37.
Parkin CG, Hinnen DA, Tetrick DL. Effective use of structured self-management of blood glucose in type 2 diabetes: lessons from the STeP study. Clin Diabetes. 2011;29(4):131–8.CrossRef
38.
Klonoff DC, Blonde L, Cembrowski G, Chacra AR, Charpentier G, Colagiuri S, et al. Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2011;5(6):1529–48.PubMedPubMedCentralCrossRef
39.
Fisher L, Polonsky WH, Parkin CG, Jelsovsky Z, Petersen B, Wagner RS. The impact of structured blood glucose testing on attitudes toward self-management among poorly controlled, insulin-naïve patients with type 2 diabetes. Diabetes Res Clin Pract. 2012;96(2):149–55.PubMedCrossRef
40.
Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R, et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care. 2013;36(10):2887–94.PubMedPubMedCentralCrossRef
41.
Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, et al. Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in central and Eastern Europe—recommendations from the international central-eastern European expert group. Diabetes Technol Ther. 2014;16(7):460–75.PubMedPubMedCentralCrossRef
42.
Silva DD, Bosco AA. An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12 weeks: a randomized, controlled pilot study. Diabetol Metab Syndr. 2015;7:2.PubMedPubMedCentralCrossRef
43.
Klonoff DC. New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly. J Diabetes Sci Technol. 2008;2(3):342–8.PubMedPubMedCentralCrossRef
44.
45.
American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes 2018. Diabetes Care. 2018;41(Suppl 1):S137–43.CrossRef
46.
Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111(1):1–9.PubMedCrossRef
47.
Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271–8.PubMedCrossRef
48.
Kesavadev J, Shankar A, Pillai PB, Krishnan G, Jothydev S. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus—a retrospective study. Diabetes Technol Ther. 2012;14(9):772–6.PubMedCrossRef
49.
50.
Shiraiwa T, Takahara M, Kaneto H, Miyatsuka T, Yamamoto K, Yoshiuchi K, et al. Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy. Diabetes Res Clin Pract. 2010;90(3):e91–2.PubMedCrossRef
51.
Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Prefer Adherence. 2014;8:237–46.PubMedPubMedCentral
52.
Ward JE, Stetson BA, Mokshagundam SP. Patient perspectives on self-monitoring of blood glucose: perceived recommendations, behaviors and barriers in a clinic sample of adults with type 2 diabetes. J Diabetes Metab Disord. 2015;14:43.PubMedPubMedCentralCrossRef
53.
Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A, et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ. 2008;336(7654):1177–80.PubMedPubMedCentralCrossRef
54.
O'Kane MJ, Bunting B, Copeland M, Coates VE, ESMON Study Group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008;336(7654):1174–7.PubMedPubMedCentralCrossRef
55.
Heisler M, Vijan S, Anderson RM, Ubel PA, Bernstein SJ, Hofer TP. When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med. 2003;18(11):893–902.PubMedPubMedCentralCrossRef
56.
57.
Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol. 2012;6(5):1060–75.PubMedPubMedCentralCrossRef
58.
Baumstark A, Jendrike N, Liebing C, Haug C, Freckmann G. System accuracy and user performance evaluation of an improved system for self-monitoring of blood glucose. J Diabetes Sci Technol. 2018;12(2):407–11.PubMedCrossRef
59.
60.
Stephan P, Schmid C, Freckmann G, Pleus S, Haug C, Müller P. The rectangle target plot: a new approach to the graphical presentation of accuracy of systems for self-monitoring of blood glucose. J Diabetes Sci Technol. 2015;10(2):343–9.PubMedPubMedCentralCrossRef
61.
Müller P, Hattemer A, Stephan P. Assessing system accuracy of blood glucose monitoring systems using rectangle target plots. J Diabetes Sci Technol. 2015;10(2):350–65.PubMedPubMedCentralCrossRef
62.
Agborsangaya CB, Robitaille C, Dunbar P, Langlois MF, Leiter LA, Dai S, et al. Self-monitoring of blood glucose in type 2 diabetes: results of the 2011 survey on living with chronic diseases in Canada. Health Rep. 2013;24(6):3–8.PubMed
63.
Barnard KD, Young AJ, Waugh NR. Self monitoring of blood glucose—a survey of diabetes UK members with type 2 diabetes who use SMBG. BMC Res Notes. 2010;3:318.PubMedPubMedCentralCrossRef
64.
Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab. 2008;10(12):1239–47.PubMed
65.
Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29(8):1757–63.PubMedPubMedCentralCrossRef
66.
McAndrew L, Schneider SH, Burns E, Leventhal H. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ. 2007;33(6):991–1011. discussion 1012-3PubMedCrossRef
67.
Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013;36(7):2009–14.PubMedPubMedCentralCrossRef
68.
Morgan CL, Griffin A, Chamberlain GH, Turkiendorf A, McEwan P, Evans LM, et al. A longitudinal study into the new and long-term use of self-monitoring blood glucose strips in the UK. Diabetes Ther. 2010;1(1):1–9.PubMedPubMedCentralCrossRef
69.
Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928–32.PubMedCrossRef
70.
Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11–7.PubMedCrossRef
71.
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef
72.
International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1–52.CrossRef
73.
Bailey TS, Grunberger G, Bode BW, Handelsman Y, Hirsch IB, Jovanovič L, et al. American Association of Clinical Endocrinologists and American College of endocrinology 2016 outpatient glucose monitoring consensus statement. Endocr Pract. 2016;22(2):231–61.PubMedCrossRef
74.
Ji L, Su Q, Feng B, Shan Z, Hu R, Xing X, et al. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: results from COMPASS. J Diabetes. 2017;9(5):495–501.PubMedCrossRef
75.
Ceriello A. Self-monitoring of blood glucose in type 2 diabetes: is the debate (finally) ending? Diabetes Res Clin Pract. 2012;97(1):1–2.PubMedCrossRef
76.
77.
Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28(6):1510–7.PubMedCrossRef
78.
Towfigh A, Romanova M, Weinreb JE, Munjas B, Suttorp MJ, Zhou A, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008;14(7):468–75.PubMed
79.
Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012;1:CD005060.PubMed
80.
Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, et al. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012;e486:344.
81.
Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton AM, et al. Self-monitoring of blood glucose in type 2 diabetes: recent studies. J Diabetes Sci Technol. 2013;7(2):478–88.PubMedPubMedCentralCrossRef
82.
Parsons S, Luzio S, Owens DR. The SMBG study: structured self-monitoring of blood glucose in non-insulin treated type 2 diabetes. IDF congress 2017; 4–8 December Abu Dhabi; Abstract OP-0073.
83.
Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients’ perspectives. BMJ. 2007;335(7618):493.PubMedPubMedCentralCrossRef
84.
Fisher L, Polonsky W, Parkin CG, Jelsovsky Z, Amstutz L, Wagner RS. The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes. Curr Med Res Opin. 2011;27(Suppl 3):39–46.PubMedCrossRef
85.
Allemann S, Houriet C, Diem P, Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin. 2009;25(12):2903–13.PubMedCrossRef
86.
Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M, et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2(3):203–11.PubMedCrossRef
87.
Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L, et al. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med. 2011;28(7):789–96.PubMedCrossRef
88.
Kempf K, Tankova T, Martin S. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin. Diabetes Technol Ther. 2013;15(1):89–96.PubMedCrossRef
89.
Harashima S, Nishimura A, Ikeda K, Wang Y, Liu Y, Inagaki N. Once daily self-monitoring of blood glucose (SMBG) improves glycemic control in oral hypoglycemic agents (OHA)-treated diabetes: SMBG-OHA follow-up study. J Diabetes Sci Technol. 2015;10(2):378–82.PubMedPubMedCentralCrossRef
90.
Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335(7611):132.PubMedPubMedCentralCrossRef
91.
Zarkogianni K, Litsa E, Mitsis K, Wu PY, Kaddi CD, Cheng CW, et al. A review of emerging technologies for the management of diabetes mellitus. IEEE Trans Biomed Eng. 2015;62(12):2735–49.PubMedPubMedCentralCrossRef
92.
93.
Bajaj S. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017. Int J Diabetes Dev Ctries. 2018;38(Suppl 1):1–115.PubMedPubMedCentralCrossRef
94.
HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRef
95.
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86.PubMedCrossRef
96.
IDF Clinical Guidelines Task Force. Global guideline on pregnancy and diabetes. Brussels: International Diabetes Federation; 2009.
97.
Wahabi HA, Alzeidan RA, Esmaeil SA. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health. 2012;12:792.PubMedPubMedCentralCrossRef
98.
99.
100.
101.
Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation. Diabetes Technol Ther. 2011;13(9):959–65.PubMedCrossRef
102.
103.
Unnikrishnan R, Mohan V. Protocols of SMBG in various insulin regimens—a practical guide for titration and control. Frontiers in Medicine. 2009;23:39–41.
104.
SMBG International Working Group. Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison. Diabetes Res Clin Pract. 2008;82(3):e15–8.CrossRef
105.
Nagpal J, Bhartia A. Quality of diabetes care in the middle- and high-income group populace: the Delhi diabetes community (DEDICOM) survey. Diabetes Care. 2006;29(11):2341–8.PubMedCrossRef
106.
Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The fremantle diabetes study. Diabetes Care. 2006;29(8):1764–70.PubMedCrossRef
107.
Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S. Self-monitoring of blood glucose among diabetes patients attending government health clinics. Med J Malaysia. 2007;62(2):147–51.PubMed
108.
Mohan V, Deepa R, Shefali AK, Poongothai S, Monica M, Karkuzhali K. Evaluation of one touch HORIZON—a highly affordable glucose monitor. J Assoc Physicians India. 2004;52:779–82.PubMed
109.
Krishnan V, Thirunavukkarasu J. Assessment of knowledge of self blood glucose monitoring and extent of self titration of anti-diabetic drugs among diabetes mellitus patients—a cross sectional, community based study. J Clin Diagn Res. 2016;10(3):FC09–11.PubMedPubMedCentral
110.
Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60(12):2342–56.PubMedPubMedCentralCrossRef
Metadata
Title
RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India
Authors
P. V. Rao
B. M. Makkar
Ajay Kumar
A. K. Das
A. K. Singh
Ambrish Mithal
Anil Bhansali
Anoop Misra
Anuj Maheshwari
Arvind Gupta
Ashu Rustogi
Banshi Saboo
C. H. Vasanth Kumar
C. R. Anand Moses
Hemant Thacker
Jayant Panda
Jayaprakashsai Jana
Jothydev Kesavdev
K. R. Narasimha Setty
Manoj Chawla
Neeta Deshpande
Nikhil Tandon
Rajeev Chawla
Rajeev Kovil
Rakesh Sahay
S. V. Madhu
Samar Banerjee
Sanjay Agarwal
Sanjay Kalra
Sarita Bajaj
Shashank R Joshi
S. R. Aravind
Subhankar Chowdhury
Sujoy Ghosh
Sunil Gupta
Viswanathan Mohan
Vijay Panikar
Vijay Viswanathan
Publication date
01-09-2018
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2018
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0677-3

Other articles of this Issue 3/2018

International Journal of Diabetes in Developing Countries 3/2018 Go to the issue

Letter to the Editor

Is the CANVAS of canaglifozin wide?

Editorial

Psychological comorbidity in diabetes mellitus—need for early recognition and treatment

Original Article

Depression and mild cognitive impairment (MCI) among elderly patients with type 2 diabetes mellitus in Pakistan: possible determinants

Original Article

Bacillus-produced surfactin for intranasal delivery of insulin in diabetic mice

Original Article

Psychosocial factors and glycemic control in insulin-naïve and insulin-experienced people with type 2 diabetes: a path analysis model

Original Article

Factors affecting risk of anxiety and depression among diabetic and hypertensive patients who refer to family health centers

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits